Actigraphy for the assessment of sleep measures in Parkinson's disease

To assess the usefulness of actigraphy for assessment of nighttime sleep measures in patients with Parkinson's disease (PD). Participants underwent overnight sleep assessment simultaneously by polysomnography (PSG) and actigraphy. Overnight sleep study in academic sleep research laboratory. Six...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep (New York, N.Y.) N.Y.), 2013-08, Vol.36 (8), p.1209-1217
Hauptverfasser: Maglione, Jeanne E, Liu, Lianqi, Neikrug, Ariel B, Poon, Tina, Natarajan, Loki, Calderon, Joanna, Avanzino, Julie A, Corey-Bloom, Jody, Palmer, Barton W, Loredo, Jose S, Ancoli-Israel, Sonia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1217
container_issue 8
container_start_page 1209
container_title Sleep (New York, N.Y.)
container_volume 36
creator Maglione, Jeanne E
Liu, Lianqi
Neikrug, Ariel B
Poon, Tina
Natarajan, Loki
Calderon, Joanna
Avanzino, Julie A
Corey-Bloom, Jody
Palmer, Barton W
Loredo, Jose S
Ancoli-Israel, Sonia
description To assess the usefulness of actigraphy for assessment of nighttime sleep measures in patients with Parkinson's disease (PD). Participants underwent overnight sleep assessment simultaneously by polysomnography (PSG) and actigraphy. Overnight sleep study in academic sleep research laboratory. Sixty-one patients (mean age 67.74 ± 8.88 y) with mild to moderate PD. Sleep measures including total sleep time (TST), sleep efficiency (SE), wake after sleep onset (WASO), and sleep onset latency (SOL) were calculated independently from data derived from PSG and from actigraphy. Different actigraphy scoring settings were compared. No single tested actigraphy scoring setting was optimal for all sleep measures. A customized setting of an activity threshold of 10, with five consecutive immobile minutes for sleep onset, yielded the combination of mean TST, SE, and WASO values that best approximated mean values determined by PSG with differences of 6.05 ± 85.67 min for TST, 1.1 ± 0.641% for SE, and 4.35 ± 59.56 min for WASO. There were significant but moderate correlations between actigraphy and PSG measurements (rs = 0.496, P < 0.001 for TST, rs = 0.384, P = 0.002 for SE, and rs = 0.400, P = 0.001 for WASO) using these settings. Greater disease stage was associated with greater differences between TST (R(2) = 0.099, beta = 0.315, P = 0.018), SE (R(2) = 0.107, beta = 0.327, P = 0.014), and WASO (R(2) = 0.094, beta = 0.307, P = 0.021) values derived by actigraphy and PSG explaining some of the variability. Using a setting of 10 immobile min for sleep onset yielded a mean SOL that was within 1 min of that estimated by PSG. However SOL values determined by actigraphy and PSG were not significantly correlated at any tested setting. Our results suggest that actigraphy may be useful for measurement of mean TST, SE, and WASO values in groups of patients with mild to moderate Parkinson's disease. However, there is a significant degree of variability in accuracy among individual patients. The importance of determining optimal scoring parameters for each population studied is underscored.
doi_str_mv 10.5665/sleep.2888
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3700718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1417528760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-555ff137aa0d18110ebe30cdb6ed2622a81eb0d970d41d05ff5fb48d3892d6f13</originalsourceid><addsrcrecordid>eNpVkM1Lw0AQxRdRtFYv_gGyN0VInUmyyeYilOIXFPSg52WTndhoPupOKvjfG9sqehqG95s3jyfECcJEJYm65JpoOQm11jtihEpBkCFku2IEmGCgEdSBOGR-hWGPs2hfHIRRBnGicSRupkVfvXi7XHzKsvOyX5C0zMTcUNvLrpRrd9mQ5ZUnllUrH61_q1ru2jOWruJBoSOxV9qa6Xg7x-L55vppdhfMH27vZ9N5UMRx3AdKqbLEKLUWHGpEoJwiKFyekAuTMLQaKQeXpeBidDDAqsxj7SKdhS4ZLsfiauO7XOUNuWLI6G1tlr5qrP80na3Mf6WtFual-zBRCpCiHgzOtwa-e18R96apuKC6ti11KzYYY6pCnSYwoBcbtPAds6fy9w2C-S7erKsx38UP8OnfYL_oT9PRFxvXgMs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1417528760</pqid></control><display><type>article</type><title>Actigraphy for the assessment of sleep measures in Parkinson's disease</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Maglione, Jeanne E ; Liu, Lianqi ; Neikrug, Ariel B ; Poon, Tina ; Natarajan, Loki ; Calderon, Joanna ; Avanzino, Julie A ; Corey-Bloom, Jody ; Palmer, Barton W ; Loredo, Jose S ; Ancoli-Israel, Sonia</creator><creatorcontrib>Maglione, Jeanne E ; Liu, Lianqi ; Neikrug, Ariel B ; Poon, Tina ; Natarajan, Loki ; Calderon, Joanna ; Avanzino, Julie A ; Corey-Bloom, Jody ; Palmer, Barton W ; Loredo, Jose S ; Ancoli-Israel, Sonia</creatorcontrib><description>To assess the usefulness of actigraphy for assessment of nighttime sleep measures in patients with Parkinson's disease (PD). Participants underwent overnight sleep assessment simultaneously by polysomnography (PSG) and actigraphy. Overnight sleep study in academic sleep research laboratory. Sixty-one patients (mean age 67.74 ± 8.88 y) with mild to moderate PD. Sleep measures including total sleep time (TST), sleep efficiency (SE), wake after sleep onset (WASO), and sleep onset latency (SOL) were calculated independently from data derived from PSG and from actigraphy. Different actigraphy scoring settings were compared. No single tested actigraphy scoring setting was optimal for all sleep measures. A customized setting of an activity threshold of 10, with five consecutive immobile minutes for sleep onset, yielded the combination of mean TST, SE, and WASO values that best approximated mean values determined by PSG with differences of 6.05 ± 85.67 min for TST, 1.1 ± 0.641% for SE, and 4.35 ± 59.56 min for WASO. There were significant but moderate correlations between actigraphy and PSG measurements (rs = 0.496, P &lt; 0.001 for TST, rs = 0.384, P = 0.002 for SE, and rs = 0.400, P = 0.001 for WASO) using these settings. Greater disease stage was associated with greater differences between TST (R(2) = 0.099, beta = 0.315, P = 0.018), SE (R(2) = 0.107, beta = 0.327, P = 0.014), and WASO (R(2) = 0.094, beta = 0.307, P = 0.021) values derived by actigraphy and PSG explaining some of the variability. Using a setting of 10 immobile min for sleep onset yielded a mean SOL that was within 1 min of that estimated by PSG. However SOL values determined by actigraphy and PSG were not significantly correlated at any tested setting. Our results suggest that actigraphy may be useful for measurement of mean TST, SE, and WASO values in groups of patients with mild to moderate Parkinson's disease. However, there is a significant degree of variability in accuracy among individual patients. The importance of determining optimal scoring parameters for each population studied is underscored.</description><identifier>ISSN: 0161-8105</identifier><identifier>EISSN: 1550-9109</identifier><identifier>DOI: 10.5665/sleep.2888</identifier><identifier>PMID: 23904681</identifier><language>eng</language><publisher>United States: Associated Professional Sleep Societies, LLC</publisher><subject>Actigraphy - methods ; Actigraphy for Assessment of Sleep in Parkinson's Disease ; Aged ; Female ; Humans ; Male ; Parkinson Disease - physiopathology ; Polysomnography ; Sleep - physiology</subject><ispartof>Sleep (New York, N.Y.), 2013-08, Vol.36 (8), p.1209-1217</ispartof><rights>2013 Associated Professional Sleep Societies, LLC. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-555ff137aa0d18110ebe30cdb6ed2622a81eb0d970d41d05ff5fb48d3892d6f13</citedby><cites>FETCH-LOGICAL-c444t-555ff137aa0d18110ebe30cdb6ed2622a81eb0d970d41d05ff5fb48d3892d6f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23904681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maglione, Jeanne E</creatorcontrib><creatorcontrib>Liu, Lianqi</creatorcontrib><creatorcontrib>Neikrug, Ariel B</creatorcontrib><creatorcontrib>Poon, Tina</creatorcontrib><creatorcontrib>Natarajan, Loki</creatorcontrib><creatorcontrib>Calderon, Joanna</creatorcontrib><creatorcontrib>Avanzino, Julie A</creatorcontrib><creatorcontrib>Corey-Bloom, Jody</creatorcontrib><creatorcontrib>Palmer, Barton W</creatorcontrib><creatorcontrib>Loredo, Jose S</creatorcontrib><creatorcontrib>Ancoli-Israel, Sonia</creatorcontrib><title>Actigraphy for the assessment of sleep measures in Parkinson's disease</title><title>Sleep (New York, N.Y.)</title><addtitle>Sleep</addtitle><description>To assess the usefulness of actigraphy for assessment of nighttime sleep measures in patients with Parkinson's disease (PD). Participants underwent overnight sleep assessment simultaneously by polysomnography (PSG) and actigraphy. Overnight sleep study in academic sleep research laboratory. Sixty-one patients (mean age 67.74 ± 8.88 y) with mild to moderate PD. Sleep measures including total sleep time (TST), sleep efficiency (SE), wake after sleep onset (WASO), and sleep onset latency (SOL) were calculated independently from data derived from PSG and from actigraphy. Different actigraphy scoring settings were compared. No single tested actigraphy scoring setting was optimal for all sleep measures. A customized setting of an activity threshold of 10, with five consecutive immobile minutes for sleep onset, yielded the combination of mean TST, SE, and WASO values that best approximated mean values determined by PSG with differences of 6.05 ± 85.67 min for TST, 1.1 ± 0.641% for SE, and 4.35 ± 59.56 min for WASO. There were significant but moderate correlations between actigraphy and PSG measurements (rs = 0.496, P &lt; 0.001 for TST, rs = 0.384, P = 0.002 for SE, and rs = 0.400, P = 0.001 for WASO) using these settings. Greater disease stage was associated with greater differences between TST (R(2) = 0.099, beta = 0.315, P = 0.018), SE (R(2) = 0.107, beta = 0.327, P = 0.014), and WASO (R(2) = 0.094, beta = 0.307, P = 0.021) values derived by actigraphy and PSG explaining some of the variability. Using a setting of 10 immobile min for sleep onset yielded a mean SOL that was within 1 min of that estimated by PSG. However SOL values determined by actigraphy and PSG were not significantly correlated at any tested setting. Our results suggest that actigraphy may be useful for measurement of mean TST, SE, and WASO values in groups of patients with mild to moderate Parkinson's disease. However, there is a significant degree of variability in accuracy among individual patients. The importance of determining optimal scoring parameters for each population studied is underscored.</description><subject>Actigraphy - methods</subject><subject>Actigraphy for Assessment of Sleep in Parkinson's Disease</subject><subject>Aged</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Parkinson Disease - physiopathology</subject><subject>Polysomnography</subject><subject>Sleep - physiology</subject><issn>0161-8105</issn><issn>1550-9109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1Lw0AQxRdRtFYv_gGyN0VInUmyyeYilOIXFPSg52WTndhoPupOKvjfG9sqehqG95s3jyfECcJEJYm65JpoOQm11jtihEpBkCFku2IEmGCgEdSBOGR-hWGPs2hfHIRRBnGicSRupkVfvXi7XHzKsvOyX5C0zMTcUNvLrpRrd9mQ5ZUnllUrH61_q1ru2jOWruJBoSOxV9qa6Xg7x-L55vppdhfMH27vZ9N5UMRx3AdKqbLEKLUWHGpEoJwiKFyekAuTMLQaKQeXpeBidDDAqsxj7SKdhS4ZLsfiauO7XOUNuWLI6G1tlr5qrP80na3Mf6WtFual-zBRCpCiHgzOtwa-e18R96apuKC6ti11KzYYY6pCnSYwoBcbtPAds6fy9w2C-S7erKsx38UP8OnfYL_oT9PRFxvXgMs</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Maglione, Jeanne E</creator><creator>Liu, Lianqi</creator><creator>Neikrug, Ariel B</creator><creator>Poon, Tina</creator><creator>Natarajan, Loki</creator><creator>Calderon, Joanna</creator><creator>Avanzino, Julie A</creator><creator>Corey-Bloom, Jody</creator><creator>Palmer, Barton W</creator><creator>Loredo, Jose S</creator><creator>Ancoli-Israel, Sonia</creator><general>Associated Professional Sleep Societies, LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130801</creationdate><title>Actigraphy for the assessment of sleep measures in Parkinson's disease</title><author>Maglione, Jeanne E ; Liu, Lianqi ; Neikrug, Ariel B ; Poon, Tina ; Natarajan, Loki ; Calderon, Joanna ; Avanzino, Julie A ; Corey-Bloom, Jody ; Palmer, Barton W ; Loredo, Jose S ; Ancoli-Israel, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-555ff137aa0d18110ebe30cdb6ed2622a81eb0d970d41d05ff5fb48d3892d6f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Actigraphy - methods</topic><topic>Actigraphy for Assessment of Sleep in Parkinson's Disease</topic><topic>Aged</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Parkinson Disease - physiopathology</topic><topic>Polysomnography</topic><topic>Sleep - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maglione, Jeanne E</creatorcontrib><creatorcontrib>Liu, Lianqi</creatorcontrib><creatorcontrib>Neikrug, Ariel B</creatorcontrib><creatorcontrib>Poon, Tina</creatorcontrib><creatorcontrib>Natarajan, Loki</creatorcontrib><creatorcontrib>Calderon, Joanna</creatorcontrib><creatorcontrib>Avanzino, Julie A</creatorcontrib><creatorcontrib>Corey-Bloom, Jody</creatorcontrib><creatorcontrib>Palmer, Barton W</creatorcontrib><creatorcontrib>Loredo, Jose S</creatorcontrib><creatorcontrib>Ancoli-Israel, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Sleep (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maglione, Jeanne E</au><au>Liu, Lianqi</au><au>Neikrug, Ariel B</au><au>Poon, Tina</au><au>Natarajan, Loki</au><au>Calderon, Joanna</au><au>Avanzino, Julie A</au><au>Corey-Bloom, Jody</au><au>Palmer, Barton W</au><au>Loredo, Jose S</au><au>Ancoli-Israel, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Actigraphy for the assessment of sleep measures in Parkinson's disease</atitle><jtitle>Sleep (New York, N.Y.)</jtitle><addtitle>Sleep</addtitle><date>2013-08-01</date><risdate>2013</risdate><volume>36</volume><issue>8</issue><spage>1209</spage><epage>1217</epage><pages>1209-1217</pages><issn>0161-8105</issn><eissn>1550-9109</eissn><abstract>To assess the usefulness of actigraphy for assessment of nighttime sleep measures in patients with Parkinson's disease (PD). Participants underwent overnight sleep assessment simultaneously by polysomnography (PSG) and actigraphy. Overnight sleep study in academic sleep research laboratory. Sixty-one patients (mean age 67.74 ± 8.88 y) with mild to moderate PD. Sleep measures including total sleep time (TST), sleep efficiency (SE), wake after sleep onset (WASO), and sleep onset latency (SOL) were calculated independently from data derived from PSG and from actigraphy. Different actigraphy scoring settings were compared. No single tested actigraphy scoring setting was optimal for all sleep measures. A customized setting of an activity threshold of 10, with five consecutive immobile minutes for sleep onset, yielded the combination of mean TST, SE, and WASO values that best approximated mean values determined by PSG with differences of 6.05 ± 85.67 min for TST, 1.1 ± 0.641% for SE, and 4.35 ± 59.56 min for WASO. There were significant but moderate correlations between actigraphy and PSG measurements (rs = 0.496, P &lt; 0.001 for TST, rs = 0.384, P = 0.002 for SE, and rs = 0.400, P = 0.001 for WASO) using these settings. Greater disease stage was associated with greater differences between TST (R(2) = 0.099, beta = 0.315, P = 0.018), SE (R(2) = 0.107, beta = 0.327, P = 0.014), and WASO (R(2) = 0.094, beta = 0.307, P = 0.021) values derived by actigraphy and PSG explaining some of the variability. Using a setting of 10 immobile min for sleep onset yielded a mean SOL that was within 1 min of that estimated by PSG. However SOL values determined by actigraphy and PSG were not significantly correlated at any tested setting. Our results suggest that actigraphy may be useful for measurement of mean TST, SE, and WASO values in groups of patients with mild to moderate Parkinson's disease. However, there is a significant degree of variability in accuracy among individual patients. The importance of determining optimal scoring parameters for each population studied is underscored.</abstract><cop>United States</cop><pub>Associated Professional Sleep Societies, LLC</pub><pmid>23904681</pmid><doi>10.5665/sleep.2888</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-8105
ispartof Sleep (New York, N.Y.), 2013-08, Vol.36 (8), p.1209-1217
issn 0161-8105
1550-9109
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3700718
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Actigraphy - methods
Actigraphy for Assessment of Sleep in Parkinson's Disease
Aged
Female
Humans
Male
Parkinson Disease - physiopathology
Polysomnography
Sleep - physiology
title Actigraphy for the assessment of sleep measures in Parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Actigraphy%20for%20the%20assessment%20of%20sleep%20measures%20in%20Parkinson's%20disease&rft.jtitle=Sleep%20(New%20York,%20N.Y.)&rft.au=Maglione,%20Jeanne%20E&rft.date=2013-08-01&rft.volume=36&rft.issue=8&rft.spage=1209&rft.epage=1217&rft.pages=1209-1217&rft.issn=0161-8105&rft.eissn=1550-9109&rft_id=info:doi/10.5665/sleep.2888&rft_dat=%3Cproquest_pubme%3E1417528760%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1417528760&rft_id=info:pmid/23904681&rfr_iscdi=true